Insulin resistance and renal disease

Contributions to Nephrology

Volumn 151, Issue , 2006, Pages 203-211

  Fliser, Danilo ^a   Kielstein, Jan T ^a   Menne, Jan ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HUMAN; INSULIN RESISTANCE; KIDNEY DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; HUMANS; INSULIN RESISTANCE; KIDNEY DISEASES; RISK FACTORS;

EID: 33748070826     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095330     Document Type: Review

References (42)

1. Reilly MP, Rader DJ: The metabolic syndrome: more than the sum of its parts? Circulation 2003;108:1546-1551.
2. Wallace TM, Matthews DR: The assessment of insulin resistance in man. Diabet Med 2002;19:527-534.
3. Neubauer E: Über Hyperglykämie bei Hochdrucknephritis und die Beziehung zwischen Glykämie und Glucosurie beim Diabetes mellitus. Biochem Z 1910;25:285-289.
4. DeFronzo RA, Alverstrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 1981;67:563-572.
5. Feneberg R, Sparber M, Veldhuis JD, Mehls O, Ritz E, Schaefer F: Altered temporal organization of plasma insulin oscillations in chronic renal failure. J Clin Endocrinol Metab 2002;87: 1965-1973.
6. Mak RHK, DeFronzo R: Glucose and insulin metabolism in uremia. Nephron 1992;61:377-382.
7. Mak RHK: Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992;41:1049-1054.
8. Lu KC, Shieh SD, Lin SH, Chyr SH, Lin YF, Diang LK, Sheu WHH, Ding YA: Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. QJM 1994;87:359-365.
9. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995;47:200-206.
10. Spaia S, Pangalos M, Askepidis N, Pazarloglou M, Mavropoulou E, Theodoridis S, Dimitrakopoulos K, Milionis A, Vayonas G: Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients. Nephron 2000;84:320-325.
11. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S: Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995;38:565-572.
12. Vareesangthip K, Tong P, Wilkinson R, Thomas TH: Insulin resistance in adult polycystic kidney disease. Kidney Int 1997;52:503-508.
13. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Franek E, Ritz E: Insulin resistance and hyperinsulinaemia are present already in patients with incipient renal disease. Kidney Int 1998;53:1243-1247.
14. Kato Y, Hayashi M, Ohno Y, Suzawa T, Sasaki T, Saruta T: Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol 2000;54:366-373.
15. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney diseases: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2005;16:1091-1098.
16. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
17. Asia Pacific Cohort Studies Colloboration: Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 2004;33:751-758.
18. Wirthensohn G, Guder WG: Renal substrate metabolism. Physiol Rev 1986;66:469-497.
19. Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J: Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 1995;96:2528-2533.
20. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J: Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol 1998;274:E817-E26.
21. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J: Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 1998;102:619-624.
22. Cersosimo E, Garlick P, Ferretti J: Insulin regulation of renal glucose metabolism in humans. Am J Physiol 1999;276:E78-E84.
23. Meyer C, Stumvoll M, Welle S, Woerle HJ, Haymond M, Gerich J: Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am J Physiol 2003;285:E819-E26.
24. Battezzati A, Caumo A, Martino F, Sereni LP, Coppa J, Romito R, Ammatuna M, Regalia E, Matthews DE, Mazzaferro V, Luzi L: Nonhepatic glucose production in humans. Am J Physiol 2004;86:E129-E135.
25. Bergman H, Drury DR: The relationship of kidney function to the glucose utilization of the extra abdominal tissues. Am J Physiol 1938;124:279-286.
26. Ishii M, Ikeda T, Takagi M, Sugimoto T, Atarashi K, Igari T, Uehara Y, Matsuoka H, Hirata Y, Kimura K, Takeda T, Murao S: Elevated plasma catecholamines in hypertensives with primary glomerular diseases. Hypertension 1983;5:545-551.
27. Converse RL, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Tarazi FF, Victor GG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-1918.
28. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:1894-1900.
29. El-Atat FA, Stas SN, McFarlane SI, Sowers JR: The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004;15:2816-2827.
30. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouns E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169.
31. Mann JFE, Gerstein HC, Dulau-Florea I, Lonn E: Cardiovascular risk in patients with mild renal insufficiency. Kidney Int 2003;63(suppl 84):S192-S196.
32. Opie LH, Schall R: Old antihypertensives and new diabetes. J Hypertens 2004;22:1453-1458.
33. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737.
34. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141.
35. Goldstein BJ, Scalia R: Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004;89:2563-8256.
36. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-477.
37. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-174.
38. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16:2134-2140.
39. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E: Asymmetric dimethylarginine (ADMA) and progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2005;16:2456-2461.
40. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-1876.
41. Schelling JR, Sedor JR: The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J Am Soc Nephrol 2004;15:2773-2774.
42. Bagby SP: Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J Am Soc Nephrol 2004;15:2775-2791.